Effect of Vitamin D Intake in Pregnancy to Prevent Recurrence of Gestational Diabetes

Kasr El Aini Hospital

Status and phase: Unknown; Early Phase 1

Conditions: Vitamin D Intake in First Trimester and Incidence of Gestational Diabetes Recurrence

Treatments: Drug: Vitamin D

Study type: Interventional

Funder types: Other

Identifiers

NCT03701087

assistant professor

Details and patient eligibility

About

primary outcome is vitamin D intake in first trimester for pregnant women with history of gestational diabetes in previous pregnancies and incidence of gestational diabetes recurrence secondary outcome is effect of vitamin D intake on mode of delivery, apgar score and neonatal birth weight

Full description

it is a prospective randomized controlled study to determined the effect of vitamin D supplementation in pregnancy in reducing the incidence of gestational diabetes recurrence. it will be conducted at the department of obstetrics and gynecology kasr el ainy hospital faculty of medicine Cairo university from August 2018 to April 2020. we include in our study 430 pregnant women who had history of gestational diabetes in their previous pregnancies. patients with multiple pregnancy or with any medical disorder are excluded from study. BMI will be calculated for each participant at the time of admission and glucose challenge test will be performed for all patients in the first trimester to exclude diabetic patients from the study then a blood sample is taken from all patients enrolled in the study to measure the vitamin D level by ELISA (after fasting 12 hours and not have a fatty dinner) the participants will be assigned to one of three main groups according to the serum 25 OH vitamin D level. pregnant women with normal vitamin D level assigned as group A, pregnant women with lower serum level of vitamin D (>20 nmol/L) randomly divided into two groups: group B and C. Group B will be given oral vitamin D 2800 units daily till 26 week pregnancy and group C will be given Omega 3 as placebo till 26 week pregnancy. incidence of gestational diabetes will be measured in 24-26 week pregnancy with OGTT and compared in the three groups. All patients will be followed up till delivery. Mode of delivery, Apgar score and neonatal birth weight will be recorded.

Enrollment: 430 estimated patients

Sex: Female

Ages: 18 to 38 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• pregnant women with history of gestational diabetes in previous pregnancies

Exclusion criteria

• multiple pregnancy
• pregnant patient with medical disorders

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

430 participants in 3 patient groups, including a placebo group

normal serum vitamin D

No Intervention group

Description:

normal serum vitamin D

low serum level of vitamin D

Experimental group

Description:

this arm will intake vitamin D 2800 IU daily

Treatment:

Drug: Vitamin D

low serum vitamin D

Placebo Comparator group

Description:

this arm will intake placebo omega 3

Treatment:

Drug: Vitamin D